Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BK Technologies CorpBKTI · Entity 6049 | Chief Operating Officer | June 22, 2022 | June 24, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BK Technologies Corp
Report date June 22, 2022 · Filed June 24, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.48 · Expires 2032-06-22 | Direct | 30,000 |
Reported balance
After 2022-06-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-06-22 · Grant · Acquired 30,000 · Balance 30,000 F1: The option will vest (a) on June 22, 2023, as to that percentage for which the following performance criteria are met: (i) as to 50% of the shares, achievement of product cost reduction milestones by October 1, 2022; (ii) as to 30% of the shares, achievement of product lead time milestones by December 31, 2022; and (iii) as to 20% of the shares, achievement of product cost reduction milestones by September 1, 2022; or (b) as to any options that do not vest pursuant to subparagraph (a) above, upon a change in control of the Issuer on or before June 22, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: The option will vest (a) on June 22, 2023, as to that percentage for which the following performance criteria are met: (i) as to 50% of the shares, achievement of product cost reduction milestones by October 1, 2022; (ii) as to 30% of the shares, achievement of product lead time milestones by December 31, 2022; and (iii) as to 20% of the shares, achievement of product cost reduction milestones by September 1, 2022; or (b) as to any options that do not vest pursuant to subparagraph (a) above, upon a change in control of the Issuer on or before June 22, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 22, 2022 Filed Jun 24, 2022 23:28 UTC | BK Technologies Corp BKTI · Entity 6049 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001654954-22-008777 · section16.xml · derivative · entry 1 Willis Randy · CIK 0001734659 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2032-06-22 F1 · derivative.exercise_date: The option will vest (a) on June 22, 2023, as to that percentage for which the following performance criteria are met: (i) as to 50% of the shares, achievement of product cost reduction milestones by October 1, 2022; (ii) as to 30% of the shares, achievement of product lead time milestones by December 31, 2022; and (iii) as to 20% of the shares, achievement of product cost reduction milestones by September 1, 2022; or (b) as to any options that do not vest pursuant to subparagraph (a) above, upon a change in control of the Issuer on or before June 22, 2027. Read SEC document |
| March 01, 2022 Filed Mar 15, 2022 19:50 UTC | BK Technologies Corp BKTI · Entity 6049 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $2.33 | $0.00 |
DisclosureSEC source: 0001654954-22-003176 · section16.xml · derivative · entry 1 Willis Randy · CIK 0001734659 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common stock · 30,000 shares Expires 2032-03-01 F1 · derivative.exercise_date: The option is exercisable in three equal annual installments beginning on the grant date and thereafter on March 1, 2023, and March 1, 2024. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 21:26 UTC | BK Technologies Corp BKTI · Entity 6049 | GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $4.07 | $0.00 |
DisclosureSEC source: 0001654954-19-002415 · section16.xml · derivative · entry 1 Willis Randy · CIK 0001734659 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-03-05 F1 · derivative.exercise_date: The option is exercisable in five equal annual installments beginning on March 5, 2020 and thereafter on March 5, 2021, March 5, 2022, March 5, 2023 and March 5, 2024. Read SEC document |
| March 14, 2018 Filed Mar 15, 2018 20:19 UTC | BK Technologies Corp RWC · Entity 6049 | GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $3.75 | $0.00 |
DisclosureSEC source: 0001654954-18-002616 · section16.xml · derivative · entry 1 Willis Randy · CIK 0001734659 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-03-14 F1 · derivative.exercise_date: The option is exercisable in five equal annual installments beginning on March 14, 2019 and thereafter on March 14, 2020, March 14, 2021, March 14, 2022 and March 14, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.